The Role of Cardiovascular Imaging and Serum Biomarkers in Identifying Cardiotoxicity Related to Cancer Therapeutics
References
- Plana JC Galderisi M Barac A Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging Eur Heart J Cardiovasc Imaging 2014 Oct 15 10 1063 93
- Cardinale D Colombo A Bacchiani G Early detection of anthracycline cardiotoxicity and improvement with heart failure therapy Circulation 2015 Jun 2 131 22 1981 8
- Ewer MS Vooletich MT Durand JB Reversibility of trastuzumab-related cardiotoxicity: new insights based on clinical course and response to medical treatment J Clin Oncol 2005 Nov 1 23 31 7820 6
- Eschenhagen T Force T Ewer MS Cardiovascular side effects of cancer therapies: a position statement from the Heart Failure Association of the European Society of Cardiology Eur J Heart Fail 2011 Jan 13 1 1 10
- Lang RM Bierig M Devereux RB Chamber Quantification Writing Group; American Society of Echocardiography's Guidelines and Standards Committee; European Association of Echocardiography Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology J Am Soc Echocardiogr 2005 Dec 18 12 1440 63
- Hamza A Tunick PA Kronzon I Echocardiographic manifestations of complications of radiation therapy Echocardiography 2009 Jul 26 6 724 8
- Edoute Y Haim N Rinkevich D Brenner B Reisner SA Cardiac valvular vegetations in cancer patients: a prospective echocardiographic study of 200 patients Am J Med 1997 Mar 102 3 252 8
- Casey DJ Kim AY Olszewski AJ Progressive pericardial effusion during chemotherapy for advanced Hodgkin lymphoma Am J Hematol 2012 May 87 5 521 4
- Palaskas N Morgan J Daigle T Targeted Cancer Therapies With Pericardial Effusions Requiring Pericardiocentesis Focusing on Immune Checkpoint Inhibitors Am J Cardiol 2019 Apr 15 123 8 1351 7
- Badano LP Boccalini F Muraru D Current clinical applications of transthoracic three-dimensional echocardiography J Cardiovasc Ultrasound 2012 Mar 20 1 1 22
- Armstrong GT Plana JC Zhang N Screening adult survivors of childhood cancer for cardiomyopathy: comparison of echocardiography and cardiac magnetic resonance imaging J Clin Oncol 2012 Aug 10 30 23 2876 84
- Thavendiranathan P Grant AD Negishi T Plana JC Popović ZB Marwick TH Reproducibility of echocardiographic techniques for sequential assessment of left ventricular ejection fraction and volumes: application to patients undergoing cancer chemotherapy J Am Coll Cardiol 2013 Jan 8 61 1 77 84
- Thavendiranathan P Poulin F Lim KD Plana JC Woo A Marwick TH Use of myocardial strain imaging by echocardiography for the early detection of cardiotoxicity in patients during and after cancer chemotherapy: a systematic review J Am Coll Cardiol 2014 Jul 1 63 25 Pt A 2751 68
- Negishi K Negishi T Hare JL Haluska BA Plana JC Marwick TH Independent and incremental value of deformation indices for prediction of trastuzumab-induced cardiotoxicity J Am Soc Echocardiogr 2013 May 26 5 493 8
- Ali MT Yucel E Bouras S Myocardial Strain Is Associated with Adverse Clinical Cardiac Events in Patients Treated with Anthracyclines J Am Soc Echocardiogr 2016 Jun 29 6 522 527.e3
- Risum N Ali S Olsen NT Variability of global left ventricular deformation analysis using vendor dependent and independent two-dimensional speckle-tracking software in adults J Am Soc Echocardiogr 2012 Nov 25 11 1195 203
- American College of Cardiology [Internet] Washington, DC American College of Cardiology 2018 Global Longitudinal Strain for LV Function; 2018 Aug 10 [cited 2019 Sep 11]. Available from: https://www.acc.org/latest-in-cardiology/ten-points-to-remember/2018/08/10/11/01/assessment-of-left-ventricular-global-longitudinal-strain
- Schwartz RG McKenzie WB Alexander J Congestive heart failure and left ventricular dysfunction complicating doxorubicin therapy. Seven-year experience using serial radionuclide angiocardiography Am J Med 1987 Jun 82 6 1109 18
- Bellenger NG Burgess MI Ray SG Comparison of left ventricular ejection fraction and volumes in heart failure by echocardiography, radionuclide ventriculography and cardiovascular magnetic resonance; are they interchangeable? Eur Heart J 2000 Aug 21 16 1387 96
- Huang H Nijjar PS Misialek JR Accuracy of left ventricular ejection fraction by contemporary multiple gated acquisition scanning in patients with cancer: comparison with cardiovascular magnetic resonance J Cardiovasc Magn Reson 2017 Mar 24 19 1 34
- Walker J Bhullar N Fallah-Rad N Role of three-dimensional echocardiography in breast cancer: comparison with two-dimensional echocardiography, multiple-gated acquisition scans, and cardiac magnetic resonance imaging J Clin Oncol 2010 Jul 20 28 21 3429 36
- The clinical role of magnetic resonance in cardiovascular disease. Task Force of the European Society of Cardiology, in collaboration with the Association of European Paediatric Cardiologists Eur Heart J 1998 Jan 19 1 19 39
- Grothues F Smith GC Moon JC Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy Am J Cardiol 2002 Jul 1 90 1 29 34
- Armstrong AC Gidding S Gjesdal O Wu C Bluemke DA Lima JA LV mass assessed by echocardiography and CMR, cardiovascular outcomes, and medical practice JACC Cardiovasc Imaging 2012 Aug 5 8 837 48
- Tham EB Haykowsky MJ Chow K Diffuse myocardial fibrosis by T1-mapping in children with subclinical anthracycline cardiotoxicity: relationship to exercise capacity, cumulative dose and remodeling J Cardiovasc Magn Reson 2013 Jun 10 15 48
- Neilan TG Coelho-Filho OR Pena-Herrera D Left ventricular mass in patients with a cardiomyopathy after treatment with anthracyclines Am J Cardiol 2012 Dec 1 110 11 1679 86
- Mahmood SS Fradley MG Cohen JV Myocarditis in Patients Treated With Immune Checkpoint Inhibitors J Am Coll Cardiol 2018 Apr 24 71 16 1755 64
- Cardinale D Sandri MT Colombo A Prognostic value of troponin I in cardiac risk stratification of cancer patients undergoing high-dose chemotherapy Circulation 2004 Jun 8 109 22 2749 54
- Cardinale D Colombo A Torrisi R Trastuzumab-induced cardiotoxicity: clinical and prognostic implications of troponin I evaluation J Clin Oncol 2010 Sep 1 28 25 3910 6
- Sawaya H Sebag IA Plana JC Assessment of echocardiography and biomarkers for the extended prediction of cardiotoxicity in patients treated with anthracyclines, taxanes, and trastuzumab Circ Cardiovasc Imaging 2012 Sep 1 5 5 596 603
- Ky B Putt M Sawaya H Early increases in multiple biomarkers predict subsequent cardiotoxicity in patients with breast cancer treated with doxorubicin, taxanes, and trastuzumab J Am Coll Cardiol 2014 Mar 4 63 8 809 16
- Fallah-Rad N Walker JR Wassef A The utility of cardiac biomarkers, tissue velocity and strain imaging, and cardiac magnetic resonance imaging in predicting early left ventricular dysfunction in patients with human epidermal growth factor receptor II-positive breast cancer treated with adjuvant trastuzumab therapy J Am Coll Cardiol 2011 May 31 57 22 2263 70
- Putt M Hahn VS Januzzi JL Longitudinal Changes in Multiple Biomarkers Are Associated with Cardiotoxicity in Breast Cancer Patients Treated with Doxorubicin, Taxanes, and Trastuzumab Clin Chem 2015 Sep 61 9 1164 72
- Pourier MS Kapusta L van Gennip A Values of high sensitive troponin T in long-term survivors of childhood cancer treated with anthracyclines Clin Chim Acta 2015 Feb 20 441 29 32
- Upadhyay A Lopez-Mattei J Kim P Diagnostic performance of high sensitivity troponin in cancer patients J Am Coll Cardiol 2019 Mar 73 9 Suppl 1 209
- Okumura H Iuchi K Yoshida T Brain natriuretic peptide is a predictor of anthracycline-induced cardiotoxicity Acta Haematol 2000 104 4 158 63
- Dodos F Halbsguth T Erdmann E Hoppe UC Usefulness of myocardial performance index and biochemical markers for early detection of anthracycline-induced cardiotoxicity in adults Clin Res Cardiol 2008 May 97 5 318 26
- Eliaz I The Role of Galectin-3 as a Marker of Cancer and Inflammation in a Stage IV Ovarian Cancer Patient with Underlying Pro-Inflammatory Comorbidities Case Rep Oncol 2013 Jul 3 6 2 343 9
- Ky B Putt M Sawaya H Early increases in multiple biomarkers predict subsequent cardiotoxicity in patients with breast cancer treated with doxorubicin, taxanes, and trastuzumab J Am Coll Cardiol 2014 Mar 4 63 8 809 16
- Cardinale D Colombo A Lamantia G Anthracycline-induced cardiomyopathy: clinical relevance and response to pharmacologic therapy J Am Coll Cardiol 2010 Jan 19 55 3 213 20
- Zamorano JL Lancellotti P Rodriguez Muñoz D ESC Scientific Document Group 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC) Eur Heart J 2016 Sep 21 37 36 2768 2801
- Armenian SH Lacchetti C Barac A Prevention and Monitoring of Cardiac Dysfunction in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline J Clin Oncol 2017 Mar 10 35 8 893 911
- Cameron D Piccart-Gebhart MJ Gelber RD Herceptin Adjuvant (HERA) Trial Study Team 11 years' follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive early breast cancer: final analysis of the HERceptin Adjuvant (HERA) trial Lancet 2017 Mar 25 389 10075 1195 1205
- Zarifa A Albittar A Kim PY Cardiac toxicities of anticancer treatments: chemotherapy, targeted therapy and immunotherapy Curr Opin Cardiol 2019 Jul 34 4 441 450
DOI: https://doi.org/10.14797/mdcj-15-4-258 | Journal eISSN: 1947-6108
Language: English
Page range: 258 - 266
Published on: Oct 1, 2019
Published by: Houston Methodist DeBakey Heart & Vascular Center
In partnership with: Paradigm Publishing Services
Keywords:
© 2019 Ali Agha, Abdulrazzak Zarifa, Peter Kim, Cezar Iliescu, Greg Gladish, Saamir Hassan, Nicolas Palaskas, Jean B. Durand, Yang Lu, Juan Lopez-Mattei, published by Houston Methodist DeBakey Heart & Vascular Center
This work is licensed under the Creative Commons Attribution-NonCommercial 4.0 License.